This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Yu, H-H Articles by Chiang, B-L Search for Related Content PubMed PubMed Citation Articles by Yu, H-H Articles by Chiang, B-L Social Bookmarking                   What's this?

Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study

J-H Lee

L-C Wang

Y-H Yang

Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan, Republic of China

B-L Chiang

Department of Pediatrics, National Taiwan University Hospital, No. 7 Chung-Shan South Road, Taipei, Taiwan, Republic of China; gicmbor{at}ha.mc.ntu.edu.tw

The objective of this study was to investigate the manifestations, treatment and outcome of neuropsychiatric (NP) involvement in pediatric systemic lupus erythematosus (SLE) patients. The charts of 185 pediatric patients with SLE diagnosed between 1985 and 2005 in a tertiary referral hospital were retrospectively reviewed. NPSLE were defined using the American College of Rheumatology NPSLE case definitions. NPSLE developed in 34.6% (64/185) of the patients. The mean onset age was 15.2 years. Fourteen patients (21.9%) had NP manifestations on initial diagnosis of SLE. The median duration from the onset of SLE to NP manifestation was 11 months. The most frequent NP manifestations were seizure disorder (84.4%), ischemic stroke (28.1%) and psychosis (21.9%). However, the prevalence of manifestations of NPSLE might be underestimated by the retrospective design of our study. Higher mean C3/C4 levels, less percentage of anti-dsDNA antibodies elevation and higher percentage of elevated anticardiolipin antibodies were observed in NPSLE events than in non-NPSLE events (P 0.05). The mortality rate of NPSLE patients decreased from 52.2% in 1985–1994 cohort to 27.8% in 1995–2005 cohort. In the past 10 years, the leading cause of death in NPSLE patients was NPSLE itself. NPSLE is common in pediatric SLE patients. It has diverse manifestations and a high mortality.

Key Words: systemic lupus erythematosus (SLE) • neuropsychiatric manifestations

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Katramados, R Rabah, M. Adams, A. Huq, and P. Mitsias Longitudinal myelitis, aseptic meningitis, and conus medullaris infarction as presenting manifestations of pediatric sysemic lupus erythematosus Lupus, April 1, 2008; 17(4): 332 - 336. [Abstract] [PDF]

				H.-H. Yu, L.-C. Wang, J.-H. Lee, C.-C. Lee, Y.-H. Yang, and B.-L. Chiang Lymphopenia is associated with neuropsychiatric manifestations and disease activity in paediatric systemic lupus erythematosus patients Rheumatology, September 1, 2007; 46(9): 1492 - 1494. [Abstract] [Full Text] [PDF]

				M. Punaro, P. Abou-Jaoude, R. Cimaz, and B. Ranchin Unusual neurologic manifestations (II): posterior reversible encephalopathy syndrome (PRES) in the context of juvenile systemic lupus erythematosus Lupus, August 1, 2007; 16(8): 576 - 579. [Abstract] [PDF]